PROCEEDINGS OF A NATIONAL CANCER INSTITUTE WORKSHOP - MR SPECTROSCOPY AND TUMOR-CELL BIOLOGY

被引:25
作者
NEGENDANK, WG
BROWN, TR
EVELHOCH, JL
GRIFFITHS, JR
LIOTTA, LA
MARGULIS, AR
MORRISETT, JD
ROSS, BD
SHTERN, F
机构
[1] FOX CHASE CANC CTR,NMR DEPT,PHILADELPHIA,PA 19111
[2] WAYNE STATE UNIV,DEPT MED,DETROIT,MI 48202
[3] ST GEORGE HOSP,DIV BIOCHEM,LONDON,ENGLAND
[4] NCI,PATHOL LAB,ROCKVILLE,MD 20852
[5] NCI,DIAGNOST IMAGING RES BRANCH,ROCKVILLE,MD
[6] UNIV CALIF SAN FRANCISCO,DEPT RADIOL,SAN FRANCISCO,CA 94143
[7] BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030
[8] HUNTINGTON MED RES INST,PASADENA,CA
关键词
MAGNETIC RESONANCE (MR); SPECTROSCOPY; NEOPLASMS; DIAGNOSIS; MR; RADIONUCLIDE STUDIES;
D O I
10.1148/radiology.185.3.1438779
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In December 1991, the National Cancer Institute held a workshop to evaluate the role of magnetic resonance (MR) spectroscopy in human cancer biology. The clinical and basic cancer research issues requiring use of MR spectroscopy, the advantages and limitations of MR spectroscopy, and future directions in MR spectroscopy of cancer were discussed. Consensus-building panels were formed on the following four topics: cell membrane biochemistry, tumor therapeutic response or drug resistance, appropriate model systems, and potential clinical applications of MR spectroscopy. The workshop members concluded that large prospective clinical studies as well as in vivo animal and human studies to define prognostic variables should be performed, with correlation between MR spectroscopic results and biochemical and physiologic features. Studies of phospholipid metabolism, the pharmacokinetics of anticancer agents, and effects of new cancer treatments on the tumor vasculature and normal tissues are needed.
引用
收藏
页码:875 / 883
页数:9
相关论文
empty
未找到相关数据